Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 11:54 PM
Study NCT ID:
NCT04725994
Status:
RECRUITING
Last Update Posted:
2024-09-27
First Post:
2021-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
Sponsor:
Idience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-13
First Submit QC Date:
None
Study First Post Date:
2021-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-26
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL